The role and clinical implications of microRNAs in hepatocellular carcinoma
Open Access
- 31 October 2012
- journal article
- review article
- Published by Springer Nature in Science China Life Sciences
- Vol. 55 (10) , 906-919
Abstract
Hepatocellular carcinoma (HCC) is common and one of the most aggressive of all human cancers. Recent studies have indicated that miRNAs, a class of small noncoding RNAs that regulate gene expression post-transcriptionally, directly contribute to HCC by targeting many critical regulatory genes. Several miRNAs are involved in hepatitis B or hepatitis C virus replication and virus-induced changes, whereas others participate in multiple intracellular signaling pathways that modulate apoptosis, cell cycle checkpoints, and growth-factor-stimulated responses. When disturbed, these pathways appear to result in malignant transformation and ultimately HCC development. Recently, miRNAs circulating in the blood have acted as possible early diagnostic markers for HCC. These miRNA also could serve as indicators with respect to drug efficacy and be prognostic in HCC patients. Such biomarkers would assist stratification of HCC patients and help direct personalized therapy. Here, we summarize recent advances regarding the role of miRNAs in HCC development and progression. Our expectation is that these and ongoing studies will contribute to the understanding of the multiple roles of these small noncoding RNAs in liver tumorigenesis.Keywords
This publication has 143 references indexed in Scilit:
- Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapyThe Prostate, 2011
- miR-199a-3p targets CD44 and reduces proliferation of CD44 positive hepatocellular carcinoma cell linesBiochemical and Biophysical Research Communications, 2010
- Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosisBiomedicine & Pharmacotherapy, 2010
- Let-7g targets collagen type I α2 and inhibits cell migration in hepatocellular carcinomaJournal of Hepatology, 2010
- Microrna-196 Represses Bach1 Protein and Hepatitis C Virus Gene Expression in Human Hepatoma Cells Expressing Hepatitis C Viral ProteinsHepatology, 2010
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 DownregulationCancer Cell, 2009
- MicroRNAs involved in tumor suppressor and oncogene pathwaysHepatology, 2009
- Heme oxygenase-1 suppresses hepatitis C virus replication and increases resistance of hepatocytes to oxidant injuryHepatology, 2008
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007
- RETRACTED: Downregulation of miR‐122 in the rodent and human hepatocellular carcinomasJournal of Cellular Biochemistry, 2006